Update on statin-mediated anti-inflammatory activities in atherosclerosis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Seminars in Immunopathology

• Publication date

  2009-05-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00281-009-0150-yPMID 19415282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atorvastatin Efficacy in the Primary and Secondary Prevention of Cardiovascular Events

  2012cited by this paper
• Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects.

  2009cited by this paper
• Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

  2009cited by this paper
• Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway.

  2009cited by this paper
• Effects of pravastatin on the function of dendritic cells in patients with coronary heart disease.

  2009cited by this paper
• Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.

  2009cited by this paper
• Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes.

  2009cited by this paper
• Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats.

  2009cited by this paper
• Cardioprotective effects of pitavastatin on cardiac performance and remodeling in failing rat hearts.

  2009cited by this paper
• Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial nitric oxide synthase.

  2009cited by this paper
• Rosuvastatin in older patients with systolic heart failure.

  2009cited by this paper
• Rosuvastatin reduces atherosclerotic lesions and promotes progenitor cell mobilisation and recruitment in apolipoprotein E knockout mice.

  2009cited by this paper
• Pravastatin Improves Function in Hibernating Myocardium by Mobilizing CD133+ and cKit+ Bone Marrow Progenitor Cells and Promoting Myocytes to Reenter the Growth Phase of the Cardiac Cell Cycle

  2009cited by this paper
• Influence of Short-term Rosuvastatin Therapy on Endothelial Progenitor Cells and Endothelial Function

  2009cited by this paper
• Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

  2008cited by this paper
• Intravenous Rosuvastatin for Acute Stroke Treatment: An Animal Study

  2008cited by this paper
• Pravastatin attenuates carboplatin-induced cardiotoxicity via inhibition of oxidative stress associated apoptosis

  2008cited by this paper
• A gift from nature: the birth of the statins

  2008cited by this paper
• Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issues.

  2008cited by this paper
• Monocyte Chemoattractant Protein-1 Expression Is Enhanced by Granulocyte-Macrophage Colony-stimulating Factor via Jak2-Stat5 Signaling and Inhibited by Atorvastatin in Human Monocytic U937 Cells*

  2008cited by this paper
• Air Force/Texas Coronary Atherosclerosis Prevention Study

  2008cited by this paper
• Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating Bcl‐2

  2008cited by this paper
• Simvastatin-Mediated Upregulation of VEGF and BDNF, Activation of the PI3K/Akt Pathway, and Increase of Neurogenesis Are Associated with Therapeutic Improvement after Traumatic Brain Injury

  2008cited by this paper
• Effects of Pitavastatin on Adiponectin in Patients with Hyperlipidemia

  2008cited by this paper
• Increase in phosphorylation of Akt and its downstream signaling targets and suppression of apoptosis by simvastatin after traumatic brain injury.

  2008cited by this paper
• Statins Induce Regulatory T Cell Recruitment via a CCL1 Dependent Pathway1

  2008cited by this paper
• Simvastatin treatment in subjects at high cardiovascular risk modulates AT1R expression on circulating monocytes and T lymphocytes

  2008cited by this paper
• Clinical efficacy and safety of statins in managing cardiovascular risk

  2008cited by this paper
• Simvastatin impairs humoral and cell‐mediated immunity in mice by inhibiting lymphocyte homing, T‐cell activation and antigen cross‐presentation

  2008cited by this paper
• AMP‐ACTIVATED PROTEIN KINASE ACTIVATION AS A STRATEGY FOR PROTECTING VASCULAR ENDOTHELIAL FUNCTION

  2008cited by this paper
• Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure.

  2008cited by this paper
• Update on statins

  2008cited by this paper
• Pharmacological approaches to improve endothelial repair mechanisms

  2008cited by this paper
• Simvastatin: two decades in a circle.

  2008cited by this paper
• Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus.

  2008cited by this paper
• Atorvastatin attenuates cardiomyocyte loss in adult rats from protein-restricted dams.

  2008cited by this paper
• Reactive Nitrogen Species Is Required for the Activation of the AMP-activated Protein Kinase by Statin in Vivo*

  2008cited by this paper
• Rosuvastatin increases vascular endothelial PPARgamma expression and corrects blood pressure variability in obese dyslipidaemic mice.

  2008cited by this paper
• Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation.

  2008cited by this paper
• AMP-Activated Protein Kinase Promotes the Differentiation of Endothelial Progenitor Cells

  2008cited by this paper
• Dual mode of HMG-CoA reductase inhibition on dendritic cell invasion.

  2008cited by this paper
• Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes

  2008cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow.

  2008influential reference
• Possible involvement of Akt activity in endothelial dysfunction in type 2 diabetic mice.

  2008cited by this paper
• High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins.

  2008cited by this paper
• Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography: A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden

  2008cited by this paper
• High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease

  2008cited by this paper
• Atorvastatin Slows the Progression of Cardiac Remodeling in Mice with Pressure Overload and Inhibits Epidermal Growth Factor Receptor Activation

  2008cited by this paper
• Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.

  2007cited by this paper
• The GALAXY Program: an update on studies investigating efficacy and tolerability of rosuvastatin for reducing cardiovascular risk

  2007cited by this paper
• The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation.

  2007cited by this paper
• Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions.

  2007cited by this paper
• Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.

  2007cited by this paper
• Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects.

  2007cited by this paper
• Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration

  2007cited by this paper
• The PI3K/Akt Pathway Mediates the Neuroprotective Effect of Atorvastatin in Extending Thrombolytic Therapy After Embolic Stroke in the Rat

  2007cited by this paper
• Intensive statin therapy after stroke or transient ischemic attack: a SPARCLing success?

  2007cited by this paper
• Increased Soluble Fas Plasma Levels in Subjects at High Cardiovascular Risk: Atorvastatin on Inflammatory Markers (AIM) Study, a Substudy of ACTFAST

  2007cited by this paper
• Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells.

  2007cited by this paper
• Effect of High-Dose Atorvastatin on Hospitalizations for Heart Failure: Subgroup Analysis of the Treating to New Targets (TNT) Study

  2007cited by this paper
• Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.

  2007cited by this paper
• Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome.

  2007cited by this paper
• Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration.

  2007cited by this paper
• Antioxidant and antiplatelet effects of rosuvastatin in a hamster model of prediabetes.

  2007cited by this paper
• Rosuvastatin Suppresses the Inflammatory Responses Through Inhibition of c-Jun N-terminal Kinase and Nuclear Factor-κB in Endothelial Cells

  2007influential reference
• High Dosage of Simvastatin Reduces TNF-α-Induced Apoptosis of Endothelial Progenitor Cells but Fails to Prevent Apoptosis Induced by IL-1β In Vitro

  2007cited by this paper
• Rosuvastatin in older patients with systolic heart failure.

  2007cited by this paper
• Inflammation, Statin Therapy, and Risk of Stroke After an Acute Coronary Syndrome in the MIRACL Study

  2007cited by this paper
• Statin Treatment Upregulates Vascular Neuronal Nitric Oxide Synthase Through Akt/NF-&kgr;B Pathway

  2007cited by this paper
• High dosage of simvastatin reduces TNF-alpha-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1beta in vitro.

  2007cited by this paper
• Simvastatin Inhibits C-Reactive Protein-Induced Pro-Inflammatory Changes in Endothelial Cells by Decreasing Mevalonate Pathway Products

  2007cited by this paper
• Statins Disrupt CCR5 and RANTES Expression Levels in CD4+ T Lymphocytes In Vitro and Preferentially Decrease Infection of R5 Versus X4 HIV-1

  2007cited by this paper
• Mevalonate pathway: a review of clinical and therapeutical implications.

  2007cited by this paper
• The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part IV: the 1984 coronary primary prevention trial ends it--almost.

  2006cited by this paper
• Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.

  2006cited by this paper
• Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes

  2006cited by this paper
• Effect of pravastatin, simvastatin and atorvastatin on the phagocytic activity of mouse peritoneal macrophages.

  2006cited by this paper
• Statins inhibit hypoxia-induced endothelial proliferation by preventing calcium-induced ROS formation.

  2006cited by this paper
• Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.

  2006cited by this paper
• Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.

  2006cited by this paper
• Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells

  2006cited by this paper
• Risks Associated With Statin Therapy: A Systematic Overview of Randomized Clinical Trials

  2006cited by this paper
• Pravastatin Prevents Myocardium from Ischemia-Induced Fibrosis by Protecting Vascular Endothelial Cells Exposed to Oxidative Stress

  2006cited by this paper
• Lovastatin reduces apoptosis and downregulates the CD40 expression induced by TNF-alpha in cerebral vascular endothelial cells.

  2006cited by this paper
• The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study.

  2006cited by this paper
• Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.

  2006cited by this paper
• Statins reduce human blood–brain barrier permeability and restrict leukocyte migration: Relevance to multiple sclerosis

  2006cited by this paper
• Who should receive a statin these days? Lessons from recent clinical trials

  2006cited by this paper
• Pravastatin prolongs graft survival in an allogeneic rat model of orthotopic single lung transplantation.

  2006cited by this paper
• Recent Evidence for an Involvement of Rho-Kinase in Cerebral Vascular Disease

  2006cited by this paper
• Statins Activate AMP-Activated Protein Kinase In Vitro and In Vivo

  2006cited by this paper
• Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.

  2006cited by this paper
• Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials.

  2006cited by this paper
• Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin

  2006cited by this paper
• Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis.

  2006cited by this paper
• Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma

  2006cited by this paper
• Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial.

  2006cited by this paper
• Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.

  2006cited by this paper
• Effect of atorvastatin on TH1 and TH2 cytokine secreting cells during T cell activation and differentiation.

  2006cited by this paper

• IL27RA is a promising key target for statins in treating hyperlipidemia

  2026cites this paper
• Reprogramming human macrophages in symptomatic carotid stenosis: Stabilization of atherosclerotic carotid plaques.

  2025cites this paper
• Turning by-products into health: fermentation-driven production of bioactive compounds for cardiovascular disease prevention

  2025cites this paper
• Do Statins Affect Cognitive Health? A Narrative Review and Critical Analysis of the Evidence

  2024cites this paper
• Reprogramming Human Inflammatory Macrophages in Symptomatic Carotid Stenosis: Potential Mechanisms for Stabilisation of Atherosclerotic Carotid Plaques

  2024influential citation
• Off‐target effects of statins: molecular mechanisms, side effects and the emerging role of kinases

  2024cites this paper
• Longitudinal urinary neopterin is associated with hearing threshold change over time in independent older adults

  2024cites this paper
• Uncovering atherosclerotic cardiovascular disease by PET imaging

  2024cites this paper
• Treatment of Giant Cell Arteritis.

  2023cites this paper
• Inflammaging as a target for healthy ageing.

  2023cites this paper
• Cardiovascular Involvement in Tuberculosis: From Pathophysiology to Diagnosis and Complications—A Narrative Review

  2023cites this paper
• Therapeutic effects of statins on osteoarthritis: A review

  2022cites this paper
• Peripheral Monocyte percentage as a potential indicator of prognosis in patients with chronic subdural hematoma receiving conservative therapy.

  2022cites this paper
• New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease

  2022cites this paper
• Atorvastatin-Loaded Spray-Dried Plga Microparticles for Local Prevention of Intimal Hyperplasia: Drug Release Rate Optimization and Activity on Synthetic Vascular Smooth Muscle Cells

  2022cites this paper
• Fluvastatin enhances IL-33-mediated mast cell IL-6 and TNF production.

  2021cites this paper
• Monocyte to High-Density Lipoprotein Ratio Is Associated With Early Neurological Deterioration in Acute Isolated Pontine Infarction

  2021cites this paper
• Streptomyces-based cell factories for production of biomolecules and bioactive metabolites

  2021cites this paper
• Statins and Inflammation

  2021cites this paper
• Cholesterol biosynthetic pathway induces cellular senescence through ERRα

  2021cites this paper
• Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk; a randomised, controlled trial.

  2020cites this paper
• High Serum Aspartate Aminotransferase, Underweight, and Weight Loss in Older People: Results of the KITCHEN-4

  2020cites this paper
• Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies

  2019cites this paper
• Quiescencia y senescencia: enfoque traslacional al paciente oncológico y críticamente enfermo.

  2019cites this paper
• The Role of Lipids and Lipid Metabolism in Age-Related Macular Degeneration

  2019cites this paper
• Lipid profile and statin use in critical care setting: implications for kidney outcome

  2019cites this paper
• Reversing the immune ageing clock: lifestyle modifications and pharmacological interventions

  2018cites this paper
• Bioconversion of mevastatin to pravastatin by various microorganisms and its applications – A review

  2018cites this paper
• The Role of Oxidative Stress in the Pathomechanism of Congenital Malformations

  2018cites this paper
• Newer Therapies for Giant Cell Arteritis

  2017cites this paper
• Inflammatory cell content of coronary thrombi is dependent on thrombus age in patients with ST-elevation myocardial infarction.

  2017cites this paper
• Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis

  2017cites this paper
• Effects of Simvastatin Beyond Dyslipidemia: Exploring Its Antinociceptive Action in an Animal Model of Complex Regional Pain Syndrome-Type I

  2017cites this paper
• Effects of Statins and Xuezhikang on the Expression of Secretory Phospholipase A2, Group IIA in Rat Vascular Smooth Muscle Cells.

  2017cites this paper
• The Treatment of Giant Cell Arteritis

  2017cites this paper
• Therapeutic interventions for aging: the case of cellular senescence.

  2017cites this paper
• Systemic Inflammation, Atherosclerosis and Coronary Thrombosis: Of Mice and Men

  2017cites this paper
• Changes in coronary plaque morphology in patients with acute coronary syndrome versus stable angina pectoris after initiation of statin therapy

  2016cites this paper
• Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke

  2016cites this paper
• Cilostazol inhibits plasmacytoid dendritic cell activation and antigen presentation

  2015cites this paper
• Statins demonstrate a broad anti‐cytomegalovirus activity in vitro in ganciclovir‐susceptible and resistant strains

  2015cites this paper
• The Effect of Statins Use on the Risk and Outcome of Acute Bacterial Infections in Adult Patients.

  2015cites this paper
• Effect of Human Umbilical Cord Blood Stem Cells on Hepatic Regeneration and Immune Response in Liver Fibrosis in Rats

  2015cites this paper
• Is immunity a mechanism contributing to statin-induced diabetes?

  2015cites this paper
• Simvastatin suppresses breast cancer cell proliferation induced by senescent cells

  2015cites this paper
• Synthesis and Biological Evaluation of the Anti-Inflammatory Activity for some Novel Oxpholipin-11D Analogues

  2015cites this paper
• Lovastatin Inhibits Low Molecular Weight Hyaluronan Induced Chemokine Expression via LFA-1 and Decreases Bleomycin-Induced Pulmonary Fibrosis

  2014cites this paper
• Beneficial role of tamoxifen in isoproterenol-induced myocardial infarction.

  2014cites this paper
• Dendritic cells in hyperlipidemia-associated atherosclerosis

  2013cites this paper
• Rosuvastatin‐regulated post‐translational phosphoproteome in human umbilical vein endothelial cells

  2013cites this paper
• Analysis of inflammatory processes in diffuse thickening of human aorta intima

  2013cites this paper
• Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it

  2013cites this paper
• Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities

  2013cites this paper
• Rosuvastatin ameliorates high‐fat and high‐cholesterol diet‐induced nonalcoholic steatohepatitis in rats

  2013cites this paper
• Statin Treatment Increases Lifespan and Improves Cardiac Health in Drosophila by Decreasing Specific Protein Prenylation

  2012cites this paper
• Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors.

  2012cites this paper
• Statins and stent thrombosis.

  2012cites this paper
• Inhibition of MCP-1/CCR2 signaling pathway is involved in synergistic inhibitory effects of irbesartan with rosuvastatin on vascular remodeling.

  2012cites this paper
• Pravastatin reverses the membrane cholesterol reorganization induced by myocardial infarction within lipid rafts in CD14(+)/CD16(-) circulating monocytes.

  2012cites this paper
• Neutrophilic Granulocytes in the Treatment of Atherosclerosis

  2012cites this paper
• Pravastatin inhibits C-reactive protein generation induced by fibrinogen, fibrin and FDP in isolated rat vascular smooth muscle cells

  2012cites this paper
• Statins and influenza: can we move forward?

  2012cites this paper
• Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells

  2012cites this paper
• The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis

  2011cites this paper
• Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: A randomized, double‐blind, placebo‐controlled trial

  2011cites this paper
• Role of oxidative stress and antioxidant supplementation in pregnancy disorders.

  2011cites this paper
• Lipids and age-related macular degeneration.

  2011cites this paper
• Techniques and Challenges in Intima–Media Thickness Measurement for Carotid Ultrasound Images: A Review

  2011cites this paper
• Cardiovascular complications of diabetes: recent insights in pathophysiology and therapeutics

  2011cites this paper
• Correlation between lipid deposition, immune-inflammatory cell content and MHC class II expression in diffuse intimal thickening of the human aorta.

  2011cites this paper
• Unexpected protective role for Toll-like receptor 3 in the arterial wall

  2011cites this paper
• Efficient bioconversion of compactin to pravastatin by the quinoline-degrading microorganism Pseudonocardia carboxydivorans isolated from petroleum-contaminated soil.

  2011cites this paper
• Inflammatory markers in population studies of aging.

  2011cites this paper
• Postoperative Statin Therapy Attenuates the Intensity of Systemic Inflammation and Increases Fibrinolysis After Coronary Artery Bypass Grafting

  2011cites this paper
• Simvastatin treatment improves survival in a murine model of burn sepsis: Role of interleukin 6.

  2011cites this paper
• Risk of pneumonia in patients taking statins: population-based nested case-control study.

  2011cites this paper
• The pathogenesis of atherosclerosis

  2010cites this paper
• The grapefruit flavonoid naringenin as a Hepatitis C virus therapy : efficacy, mechanism and delivery

  2010cites this paper
• Inflammatory signaling in pulmonary arterial hypertension: the controversial role of CRP, and the search for new therapies.

  2010cites this paper
• Applied Healthspan Engineering

  2010cites this paper
• Statin Effects on Both Low-Density Lipoproteins and High-Density Lipoproteins: Is There a Dual Benefit?

  2010cites this paper
• In vitro antioxidant activity of pravastatin provides vascular protection.

  2010cites this paper
• Statins and inflammation: an update

  2010cites this paper
• Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus

  2010cites this paper
• Oxpholipin 11D: An Anti-Inflammatory Peptide That Binds Cholesterol and Oxidized Phospholipids

  2010cites this paper
• Clinical and genetic factors influencing cardiovascular risk in patients with familial hypercholesterolemia

  2010cites this paper
• Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis

  2009cites this paper
• Ezetimibe/simvastatin

  2009cites this paper
• Current World Literature

  2002cites this paper